Christopher P. Acevedo - 31 Dec 2024 Form 5 Insider Report for OS Therapies Inc (OSTX)

Role: Chief Financial Officer
Signature: /s/ Christopher P. Acevedo
Issuer symbol: OSTX
Transactions as of: 31 Dec 2024
Net transactions value: $0
Form type: 5
Filing time: 14 Feb 2025, 16:21:21 UTC
Previous filing: 01 Aug 2024
Next filing: 19 Dec 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OSTX	Common Stock						100,000	31 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OSTX	Non-qualified stock options (right to buy)	Award	$0	+200,000		$0.000000	200,000	05 Dec 2024	Common stock, par value $0.001 per share	200,000	$1.86	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 200,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions.